Understanding What Does Avacopan Do for Vasculitis Patients?
•
2 min read
According to the ADVOCATE clinical trial, avacopan (brand name Tavneos) led to significantly higher rates of sustained remission at 52 weeks compared to a prednisone-tapering regimen for patients with ANCA-associated vasculitis. Understanding **what does avacopan do** is crucial for patients and healthcare providers exploring this targeted treatment option.
